St. Louis, Missouri
Summary
This business specializes in predictive diagnostics for cancer treatment, utilizing next-generation RNA sequencing technology to match patients with appropriate immunotherapy options. They have developed a diagnostic assay, OncoPrism, which aims to accurately predict patient responses to immunotherapy based on tumor biopsies. The company collaborates with numerous healthcare systems for clinical trials and focuses on advancing precision medicine through multidimensional biomarker analysis.
| 172.66.40.104 |
| 172.66.43.152 |
| 188.114.96.1 |
| 188.114.97.1 |
| 1 aspmx.l.google.com. |
| 10 alt3.aspmx.l.google.com. |
| 10 alt4.aspmx.l.google.com. |
| 5 alt1.aspmx.l.google.com. |
| 5 alt2.aspmx.l.google.com. |
| matt.ns.cloudflare.com. |
| sandy.ns.cloudflare.com. |
| apple-domain-verification=g4quzminlvohiey1 |
| dropbox-domain-verification=l9awrfn897mp |
| google-site-verification=nwkymv8f1zymgd6ihsj-bcqyo06cojeob-hafupfgwk |
| logmein-verification-code=e706a5ac-7b4d-4bc6-ab45-5654e9138d2b |
| v=spf1 include:_spf.google.com ~all include:servers.mcsv.net ~all include:spf.mandrillapp.com ~all include:mail.zendesk.com ~all |